Inhibiting GS-FDH to Modulate No Bioactivity
Patients needing NO donor therapy or inhibition of pathologically proliferating cells or increased NO bioactivity are treated with a therapeutically effective amount of an inhibitor of glutathione-dependent formaldehyde dehydrogenase.
Patents:AT 510,551 [
MORE INFO]
Inventor(s):
STAMLER JONATHAN [US]; LIU LIMIN [US]; HAUSLADEN ALFRED [US]; NUDELMAN RAPHAEL [US]
Type of Offer:
Licensing
« More Medical Patents